| Literature DB >> 35369108 |
Esther Veronika Wenzel1, Kilian Johannes Carl Zilkens1.
Abstract
Despite readily available alternative technologies, many antibodies in research and diagnostics are still generated and produced with the use of laboratory animals. Here, we portrait the concept of animal-free recombinant antibodies and the generation of such an antibody against the spike-protein of SARS-Cov-2. The scientific community needs to raise awareness for more sustainable animal-free alternatives, especially as they offer a path to more reliable and reproducible data. © Springer-Verlag GmbH 2022.Entities:
Year: 2022 PMID: 35369108 PMCID: PMC8960684 DOI: 10.1007/s12268-022-1716-7
Source DB: PubMed Journal: Biospektrum (Heidelb) ISSN: 0947-0867